Biomedical Laboratory Science

ShareThis

Showing posts with label Skin. Show all posts
Showing posts with label Skin. Show all posts

Wednesday, September 7, 2016

Two-Gene Panel Differentiates between Pediatric Bacterial and Viral Infections

A two-gene panel was shown to differentiate between viral and bacterial infections in children with fevers with 95-100% accuracy.

Since clinical features do not reliably distinguish bacterial from viral infection, many children worldwide receive unnecessary antibiotic treatment, while bacterial infection is missed in others. To solve this problem, investigators at Imperial College London (United Kingdom) sought to identify a blood RNA expression signature that could distinguish bacterial from viral infection in febrile children.


An example of an approximately 40,000 probe spotted RNA microarray with enlarged inset to show
detail (Photo courtesy of Wikimedia Commons).
Source: labmedica

Saturday, May 7, 2016

Vitamin D and cardiovascular disease prevention

Vitamin D is a precursor of the steroid hormone calcitriol that is crucial for bone and mineral metabolism. Both the high prevalence of vitamin D deficiency in the general population and the identification of the vitamin D receptor in the heart and blood vessels raised interest in the potential cardiovascular effects of vitamin D. Experimental studies have demonstrated various cardiovascular protective actions of vitamin D, but vitamin D intoxication in animals is known to induce vascular calcification. In meta-analyses of epidemiological studies, vitamin D deficiency is associated with an increased cardiovascular risk. Findings from Mendelian randomization studies and randomized, controlled trials (RCTs) do not indicate significant effects of a general vitamin D supplementation on cardiovascular outcomes. Previous RCTs, however, were not adequately designed to address extra skeletal events, and did not focus on vitamin D-deficient individuals. Therefore, currently available evidence does not support cardiovascular benefits or harms of vitamin D supplementation with the commonly used doses, and whether vitamin D has cardiovascular effects in individuals with overt vitamin D deficiency remains to be evaluated. Here, we provide an update on clinical studies on vitamin D and cardiovascular risk, discuss ongoing vitamin D research, and consider the management of vitamin D deficiency from a cardiovascular health perspective.

Key points
  • The vitamin D receptor (VDR) and enzymes for vitamin D metabolism are expressed throughout the cardiovascular system
  • VDR and 1α-hydroxylase knockout mice have hypertension with myocardial hypertrophy and increased activity of the renin–angiotensin–aldosterone system
  • The molecular effects of VDR activation indicate various anti-atherosclerotic and protective effects on the heart and on common cardiovascular risk factors
  • Observational studies have shown that low 25-hydroxyvitamin D levels are associated with an adverse cardiovascular risk profile and significantly increased risk of cardiovascular events
  • Mendelian randomization studies and randomized clinical trials have not shown significant effects of vitamin D on cardiovascular events, but these trials were not designed to investigate cardiovascular outcomes in vitamin D-deficient individuals
  • Vitamin D supplementation is currently not indicated for the purpose of cardiovascular disease prevention, but treatment of vitamin D deficiency is critical for skeletal health
Introduction
The critical involvement of vitamin D in bone and mineral metabolism is historically known. The identification of the vitamin D receptor (VDR) in almost all human organs including the heart and the blood vessels, and observations that individuals deficient in vitamin D are at increased risk of various extraskeletal diseases, stimulated research on the role of vitamin D for overall and cardiovascular health. In this Review, we summarize the existing knowledge on the effects of vitamin D on cardiovascular diseases and associated risk factors, with a particular focus on meta-analyses of large, epidemiological studies and randomized, controlled trials (RCTs). First, we provide a short summary of vitamin D metabolism and current vitamin D guidelines, a historical perspective on vitamin D and cardiovascular diseases, and a brief overview on the mechanistic effects of VDR activation on cardiovascular risk factors, the blood vessels, and the heart. The principal aspect of this Review is an update on observational studies, Mendelian randomization studies, and RCTs on vitamin D and cardiovascular risk. Finally, we outline and discuss ongoing vitamin D research, including large RCTs, and present our conclusions on how to deal with the management of vitamin D deficiency from a public health and cardiovascular health perspective.


Figure 1: Human metabolism of vitamin D.


Source: NatureReviewsCardiology



Vitamin D and cardiovascular disease prevention

Sunday, May 1, 2016

Organ regeneration with skin cells turning Into brain and heart cells

In a breakthrough study, researchers were able to chemically change skin cells to heart and brain cells.

When a person’s own body fails them, there are plenty of roadblocks to getting it running again. Adult hearts have a very limited ability to regenerate, so oftentimes the only way to help a person with a failing heart is to get them a new one. This is risky, though, since the patient’s body may reject even a perfectly matched organ. Scientists have been making strides in overcoming that problem by using a patient’s own stem cells to regenerate tissue, and researchers from the Gladstone Institutes have made a major breakthrough in the area — they successfully used a combination of chemicals to transform skin cells into heart and brain cells.

The feat is unprecedented, since all previous attempts to reprogram cells required scientists to add outside genes. Published in Science and Stem Cell, the research gives scientists a foundation for one day being able to regenerate lost or damaged cells with pharmaceuticals. The system is both more reliable and efficient than previous processes, and avoids medical concerns surrounding genetic engineering.

“This method brings us closer to being able to generate new cells at the site of injury in patients,” Dr. Sheng Ding, a Gladstone senior investigator, said in a press release. “Our hope is to one day treat diseases like heart failure or Parkinson’s disease with drugs that help the heart and brain regenerate damaged areas from their own existing tissue cells. This process is much closer to the natural regeneration that happens in animals like newts and salamanders, which has long fascinated us.”


Brain cells are hard to fake, but it may now be possible.
Source: Pixabay

Wednesday, April 6, 2016

The Molecule That Gives Skin Elasticity

Through Tropoelastin's movements, it assembles to make elastic fibers, tubes and sheets for tissue repair. It is used to make and fix many different elastic tissues in the body. This material relates to the paper titled, 'Subtle balance of tropoelastin molecular shape and flexibility regulates dynamics and hierarchical assembly. [Weiss Lab, University of Sydney]

Related Posts Plugin for WordPress, Blogger...

AddToAny